What's Happening?
Stellaromics has expanded its Pyxa 3D spatial transcriptomics beta program by installing the system at Emory University School of Medicine. This marks the third installation following deployments at the University of Glasgow and the University of California,
Irvine. The Pyxa system will be used in Dr. Hailing Shi's laboratory to study the spatial organization of the central nervous system, focusing on RNA regulation and modifications related to neurodegenerative disorders. The system allows for high-resolution, multiplexed 3D spatial transcriptomics, enabling researchers to map complex tissue structures and molecular interactions.
Why It's Important?
The installation of the Pyxa system at Emory University represents a significant advancement in the field of spatial biology, particularly in understanding neurodegenerative diseases. By providing detailed insights into RNA regulation within the brain, the system could lead to breakthroughs in identifying therapeutic targets and developing new treatments for conditions like Alzheimer's and Parkinson's disease. This collaboration underscores the importance of cutting-edge technology in advancing medical research and highlights the potential for spatial transcriptomics to transform our understanding of brain health.
What's Next?
As part of the beta program, Dr. Shi's team will work closely with Stellaromics to optimize the Pyxa system's performance and streamline workflows. The insights gained from this collaboration will help shape the future development of the system, including its assay and software capabilities. The success of the beta program could lead to wider adoption of the technology in other research institutions, further accelerating discoveries in neuroscience and genetics.
